Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
| 83.81 BATS BZX Real-Time Price As of 1:25pm ET |  -0.78 / -0.92%Today’s Change | 53.15 Today|||52-Week Range 85.68 | +41.59% Year-to-Date |
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.
| Ardsley Advisory Partners Buys Alexion Pharmaceuticals Inc, New Residential Investmen... Sep 21 / GuruFocus News - Paid Partner Content | Should You Keep Your Portfolio Healthy with Biotech ETFs? Sep 12 / Zacks.com - Paid Partner Content |
| 1 month | +12.22% | 3 years | +17.49% | |
| 3 months | +7.75% | 5 years | +22.05% | |
| 1 year | +24.12% | Since inception | +15.48% |
| Previous close | $84.59 |
| Open day’s range | 83.57 – 84.18 |
| Net asset value (NAV) | 84.53 (09/21/2017) |
| Daily volume | 273,450 |
| Average volume (3 months) | 4,038,830 |
| XBI | Category | |
|---|---|---|
| Performance 5-yr return | +22.05% | +17.39% |
| Expense Gross exp ratio | 0.35% | 1.33% |
| Risk 5 year sharpe ratio | 0.84 | 1.13 |
| Net assets | $4.1B | $3.1B |
| Average market cap | $5.2B | $32.0B |
| Average P/E | -- | 22.7 |
| Dividend / Share | -- | 0.28% |
| XLV Health Care Select Sector SPDR® Fund |
| RYH Guggenheim S&P 500® Equal Weight Health... |
| FHLC Fidelity® MSCI Health Care Index ETF |
| Healthcare | 100.00% |
| Business service | 0.00% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
| KITE Kite Pharma Inc | 3.59% |
| EXEL Exelixis Inc | 2.69% |
| JUNO Juno Therapeutics Inc | 2.57% |
| ALXN Alexion Pharmaceuticals Inc | 2.40% |
| VRTX Vertex Pharmaceuticals Inc | 2.32% |
| ACAD ACADIA Pharmaceuticals Inc | 2.30% |
| NBIX Neurocrine Biosciences Inc | 2.30% |
| GILD Gilead Sciences | 2.29% |
| SRPT Sarepta Therapeutics Inc | 2.27% |
| CLVS Clovis Oncology Inc | 2.23% |
